Cell name:
HCC827
Other names for the model:
HCC-827、HCC 827、HCC0827、Hamon Cancer Center 827
Cell information:
HCC827 cells are derived from human non-small cell lung cancer cells. The cells have an acquired mutation (E746-A750 deletion) in the EGFR tyrosine kinase domain. Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is BALB/c Nude, and matrix needs to be added during inoculation. Approximately 7 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 28 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059